Integrated Psychological Therapy (IPT) / Volker RODER

Public ISBD Titre : Integrated Psychological Therapy (IPT) : For the Treatment of Neurocognition, Social Cognition, and Social Competency in Schizophrenia Patients Type de document : texte imprimé Auteurs : Volker RODER, Auteur ; Daniel MULLER, Auteur ; Hans Dieter BRENNER, Auteur ; William D. SPAULDING, Auteur ; Anna HEUBERGER, Auteur Editeur : Paris [France] : Hogrefe Année de publication : 2010 Importance : 256 p. Présentation : ill. Format : 18cm x 26cm x 2cm ISBN/ISSN/EAN : 978-0-88937-389-1 Note générale : Bibliogr. Langues : Anglais (eng) Mots-clés : Integrated Psychological Therapy - IPT Index. décimale : APP-A APP-A - ABA - FBA - Approches Comportementales Résumé : A practical, comprehensive guide to using Integrated Psychological Therapy (IPT) for Schizophrenia Patients – the highly successful empirically supported approach that has fast become a standard treatment in many psychiatric clinics around the world. The first part of this book describes and explains the basic concepts of neurocognition, social cognition, and social competency that are now allowing us a better understanding of schizophrenia. Current treatment approaches and empirical support for them are also discussed. The core of the book is a clear and structured description of the five subprograms making up IPT: Cognitive Differentiation Social Perception Verbal Communication Social Skills Interpersonal Problem-Solving Clinicians learn step by step how to apply the therapy techniques and to select the appropriate therapy materials (described in detail in practical appendices). The book also provides practical advice about dealing with group processes and individual dyadic situations. Differential indications, assessment, therapy planning and evaluation are presented. Therapists will also learn how to use IPT within multimodal therapy and rehabilitation efforts (case management; implementation of IPT). The final part of the book provides an overview of further developments of IPT: Integrated Neurocognitive Therapy (INT), conceptualized mainly for outpatients with better social functioning, and specific social skills programs for residential, vocational, and recreational rehabilitation (WAF). [Résumé d'Auteur/Editeur] Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=271 Integrated Psychological Therapy (IPT) : For the Treatment of Neurocognition, Social Cognition, and Social Competency in Schizophrenia Patients [texte imprimé] / Volker RODER, Auteur ; Daniel MULLER, Auteur ; Hans Dieter BRENNER, Auteur ; William D. SPAULDING, Auteur ; Anna HEUBERGER, Auteur . - Paris [France] : Hogrefe, 2010 . - 256 p. : ill. ; 18cm x 26cm x 2cm. ISBN : 978-0-88937-389-1 Bibliogr. Langues : Anglais (eng) Mots-clés : Integrated Psychological Therapy - IPT Index. décimale : APP-A APP-A - ABA - FBA - Approches Comportementales Résumé : A practical, comprehensive guide to using Integrated Psychological Therapy (IPT) for Schizophrenia Patients – the highly successful empirically supported approach that has fast become a standard treatment in many psychiatric clinics around the world. The first part of this book describes and explains the basic concepts of neurocognition, social cognition, and social competency that are now allowing us a better understanding of schizophrenia. Current treatment approaches and empirical support for them are also discussed. The core of the book is a clear and structured description of the five subprograms making up IPT: Cognitive Differentiation Social Perception Verbal Communication Social Skills Interpersonal Problem-Solving Clinicians learn step by step how to apply the therapy techniques and to select the appropriate therapy materials (described in detail in practical appendices). The book also provides practical advice about dealing with group processes and individual dyadic situations. Differential indications, assessment, therapy planning and evaluation are presented. Therapists will also learn how to use IPT within multimodal therapy and rehabilitation efforts (case management; implementation of IPT). The final part of the book provides an overview of further developments of IPT: Integrated Neurocognitive Therapy (INT), conceptualized mainly for outpatients with better social functioning, and specific social skills programs for residential, vocational, and recreational rehabilitation (WAF). [Résumé d'Auteur/Editeur] Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=271

Exemplaires(0)

Disponibilité
aucun exemplaire

Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability / Kazunari YOSHIDA ; Yona LUNSKY ; Daniel MULLER ; Pushpal DESARKAR in Journal of Autism and Developmental Disorders, 55-2 (February 2025)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 55-2 (February 2025) . - p.457-471 Titre : Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability : Journal of Autism and Developmental Disorders Type de document : texte imprimé Auteurs : Kazunari YOSHIDA, Auteur ; Yona LUNSKY, Auteur ; Daniel MULLER, Auteur ; Pushpal DESARKAR, Auteur Article en page(s) : p.457-471 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : The aim of this study was to compare the rates of psychotropic medication use and psychotropic polypharmacy between autistic adults with and without intellectual disability (ID) and to examine factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults, stratified by the presence of ID. We conducted a retrospective medical chart review of outpatients with an autism diagnosis aged 18 years and older. The rates of psychotropic medication use and psychotropic polypharmacy were compared between autistic adults with and without ID. Subsequently, logistic regression analyses were performed to identify factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults with ID and those without ID, respectively. The rates of prevalence of psychotropic medication use and polypharmacy were significantly higher in participants with ID than those without ID (78.6% vs. 58.8% and 49.3% vs. 31.2%; p-values < 0.05). Age, gender, race, residence, presence of mood disorders, presence of schizophrenia, absence of anxiety disorder, number of psychiatric comorbidities, and presence of behaviors that challenge were significantly associated with these outcomes, depending on the presence/absence of ID. The need to optimize pharmacotherapy in autistic adults, stratifying by the presence of ID, is highlighted. En ligne : https://doi.org/10.1007/s10803-023-06208-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=548 [article] Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability : Journal of Autism and Developmental Disorders [texte imprimé] / Kazunari YOSHIDA, Auteur ; Yona LUNSKY, Auteur ; Daniel MULLER, Auteur ; Pushpal DESARKAR, Auteur . - p.457-471. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 55-2 (February 2025) . - p.457-471 Index. décimale : PER Périodiques Résumé : The aim of this study was to compare the rates of psychotropic medication use and psychotropic polypharmacy between autistic adults with and without intellectual disability (ID) and to examine factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults, stratified by the presence of ID. We conducted a retrospective medical chart review of outpatients with an autism diagnosis aged 18 years and older. The rates of psychotropic medication use and psychotropic polypharmacy were compared between autistic adults with and without ID. Subsequently, logistic regression analyses were performed to identify factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults with ID and those without ID, respectively. The rates of prevalence of psychotropic medication use and polypharmacy were significantly higher in participants with ID than those without ID (78.6% vs. 58.8% and 49.3% vs. 31.2%; p-values < 0.05). Age, gender, race, residence, presence of mood disorders, presence of schizophrenia, absence of anxiety disorder, number of psychiatric comorbidities, and presence of behaviors that challenge were significantly associated with these outcomes, depending on the presence/absence of ID. The need to optimize pharmacotherapy in autistic adults, stratifying by the presence of ID, is highlighted. En ligne : https://doi.org/10.1007/s10803-023-06208-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=548

---

1 (1 - 2 / 2) Par page : 25 50 100 200